Scott W Lee MD
Diabetes, Lipid Metabolism
Clinical Professor of Medicine, Loma Linda University
Join to View Full Profile
11370 Anderson StLoma Linda, CA 92354
Phone+1 909-558-2870
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1993 - 1996
Northwestern University The Feinberg School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1996 - 2026
WI State Medical License 1994 - 1997
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes Start of enrollment: 2005 Jun 01
- Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration Start of enrollment: 2002 Jun 01
- Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy Start of enrollment: 2007 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia.Yi Xu, David J Baylink, Jeffrey Xiao, Lily Tran, Vinh Nguyen
International Journal of Molecular Sciences. 2024-08-05 - 6 citationsSafety and Glycemic Outcomes During the MiniMedAdvanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.Catherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, Kevin B Kaiserman, Jennifer L Sherr
Diabetes Technology & Therapeutics. 2023-11-01 - 1 citationsSafety Event Outcomes and Glycemic Control with a Hybrid Closed-Loop System Used by Chinese Adolescents and Adults with Type 1 Diabetes Mellitus.Yu Pei, Weijian Ke, Jing Lu, Yi Lin, Zhijian Zhang
Diabetes Technology & Therapeutics. 2023-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
